(Q48121459)

8 February 2018

title

Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET. (English)

1 reference

8 February 2018

0 references

0 references

1 reference

7

Långström B

1 reference

8 February 2018

Lindström LH

1

1 reference

8 February 2018

Gefvert O

2

1 reference

8 February 2018

Hagberg G

3

1 reference

8 February 2018

Lundberg T

4

1 reference

8 February 2018

Bergström M

5

1 reference

8 February 2018

Hartvig P

6

1 reference

8 February 2018

language of work or name

English

0 references

publication date

1 September 1999

1 reference

8 February 2018

published in

Biological Psychiatry

1 reference

8 February 2018

volume

46

1 reference

8 February 2018

issue

5

1 reference

8 February 2018

page(s)

681-688

1 reference

8 February 2018

Implementation and validation of a fully automatic system for intra- and interindividual registration of PET brain scans

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Correction for scattered radiation in a ring detector positron camera by integral transformation of the projections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Regional distribution of monoamines in the cerebral cortex and subcortical structures of the rhesus monkey: concentrations and in vivo synthesis rates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

[3H]DOPA formed from [3H]tyrosine in living rat brain is not committed to dopamine synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Presynaptic dopaminergic function in the striatum of schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Do organic solvents induce changes in the dopaminergic system? Positron emission tomography studies of occupationally exposed subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Possible effects of tetrahydrobiopterin treatment in six children with autism ‐ clinical and positron emission tomography data: a pilot study

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Functional and Anatomical Aspects of Prefrontal Pathology in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Brain kinetics of L-[?-11 C]DOPA in humans studied by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Dopamine in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Monoamine Neurotransmitter Interactions in Drug-Free and Neuroleptic-Treated Schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Frontal lobe dysfunctions in schizophrenia--II. Impairments of psychological and brain functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Liquid chromatographic analysis of brain homogenates and microdialysates for the quantification of L-[beta-11C]DOPA and its metabolites for the validation of positron emission tomography studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Low HVA and normal 5HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: correlations to symptomatology and family history

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Dopamine and the pharmacology of schizophrenia: the state of the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Neurologic soft signs in schizophrenia and character disorders. Organicity in schizophrenia with premorbid asociality and emotionally unstable character disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Beyond the dopamine hypothesis. The neurochemical pathology of schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Elevated dopa decarboxylase activity in living brain of patients with psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

L-DOPA modulates striatal dopaminergic function in vivo: evidence from PET investigations in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

CBA--an atlas-based software tool used to facilitate the interpretation of neuroimaging data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Effect of apomorphine infusion on dopamine synthesis rate relates to dopaminergic tone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

A meta-analysis of homovanillic acid concentrations in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Neuropathological Studies of Schizophrenia: A Selective Review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Computed tomography (CT) findings in schizophrenia: Speculation on the meaning of it all

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

CSF levels of HVA and 5-HIAA in drug-free schizophrenic patients and healthy controls: a prospective study focused on their predictive value for outcome in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900109-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(99)00109-2

1 reference

8 February 2018

1 reference

8 February 2018